AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Australian Pharma Industries

1.530

+0.000

Volume:- -

Turnover:5.18M

Market Cap:753.76M

PE:547.41

High:1.530

Open:1.530

Low:1.530

Close:1.530

Loading ...

Overview Company News Filings

Jiangsu Sinopep-Allsino Biopharmaceutical Gets EU Export Nod for Type 2 Diabetes Drug API

MT Newswires Live

Hunan Warrant Pharmaceutical to Invest Up to 500 Million Yuan in API Manufacturing Base

MT Newswires Live

Guobang Pharma Subsidiary Gains Approval for Domestic Production of Cefuroxime Axetil API

MT Newswires Live

Zhejiang Jianfeng Group Unit Secures Approval for API Market Entry

MT Newswires Live

Jiangxi Synergy Pharmaceutical Secures Drug Registration in South Korea

MT Newswires Live

Sinopep-Allsino Biopharmaceutical Passes GMP Inspections for APIs in South Korea, China

MT Newswires Live

"Nvidia's still a buy": As China's ChatGPT moment rattles tech sector

Asian Equities Traded in the US as American Depositary Receipts Advance in Thursday Trading

MT Newswires Live

JiangSu WuZhong Pharmaceutical Development Gets Registration for Eperisone Hydrochloride API

MT Newswires Live

Tianyao Pharmaceuticals Gets China Registration Approval for Formoterol API

MT Newswires Live

Zhejiang Cheng Yi Pharmaceutical Passes TGA-GMP Certification for Two APIs

MT Newswires Live

Tianjin Tianyao Pharmaceuticals Gets Listing Approval for Dexamethasone Sodium Phosphate API in Brazil

MT Newswires Live

Sector Update: Tech Stocks Mixed Premarket Monday

MT Newswires Live

Agora Senior Management Team Signs Voluntary Lock-Up Deal

MT Newswires Live

Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading

MT Newswires Live

Are Wesfarmers or Sigma shares a better buy in the pharmacy arena?

Indonesian Court Declares Textile Giant Sritex Bankrupt

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/API.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"API.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"API.AU\",,,,,undefined,":{"symbol":"API.AU","market":"AU","secType":"STK","nameCN":"Australian Pharma Industries","latestPrice":1.53,"timestamp":1745301600000,"preClose":1.53,"halted":0,"volume":0,"delay":0,"nameEN":"Australian Pharma Industries","floatShares":396917399,"shares":492656035,"eps":0.002795,"marketStatus":"Not Yet Opened","change":0,"latestTime":"04-22 16:00:00 AEST","open":1.53,"high":1.53,"low":1.53,"amount":5184735.1000092,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.002795,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1745366400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":1.53,"dividendRate":0.022876,"openAndCloseTimeList":[[1745280000000,1745301600000]],"volumeRatio":1.318654687580577,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"API.AU\",,,,,undefined,":{"symbol":"API.AU","floatShares":396917399,"roa":"2.59%","roe":"0.26%","lyrEps":0.002795,"volumeRatio":1.318654687580577,"shares":492656035,"dividePrice":0.035,"high":1.53,"amplitude":0,"preClose":1.53,"low":1.53,"week52Low":1.53,"pbRate":"1.72","week52High":1.53,"institutionHeld":0,"latestPrice":1.53,"eps":0.002795,"divideRate":0.022876,"volume":0,"delay":0,"ttmEps":0.002795,"open":1.53,"prevYearClose":1.5,"prevWeekClose":1.5,"prevMonthClose":1.5,"prevQuarterClose":1.5,"fiveDayClose":1.5,"twentyDayClose":1.5,"sixtyDayClose":1.5},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"API.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2524237249","title":"Jiangsu Sinopep-Allsino Biopharmaceutical Gets EU Export Nod for Type 2 Diabetes Drug API","url":"https://stock-news.laohu8.com/highlight/detail?id=2524237249","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524237249?lang=en_us&edition=fundamental","pubTime":"2025-04-03 19:00","pubTimestamp":1743678015,"startTime":"0","endTime":"0","summary":"Jiangsu Sinopep-Allsino Biopharmaceutical  obtained approval to export tirzepatide as an active pharmaceutical ingredient  to the European Union, according to a Thursday filing with the Shanghai Stock Exchange.Sinopep-Allsino's factory in Lianyungang passed the EU's good manufacturing practice compliance for export, the filing said.Tirzepatide is indicated for type 2 diabetes.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["OTX.SI","API","BK4023","688076","BK0239","API.AU","BK4503","BK4156","BK4535","BK6100","BK4551","BK7103","BK6520"],"gpt_icon":0},{"id":"2518829472","title":"Hunan Warrant Pharmaceutical to Invest Up to 500 Million Yuan in API Manufacturing Base","url":"https://stock-news.laohu8.com/highlight/detail?id=2518829472","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518829472?lang=en_us&edition=fundamental","pubTime":"2025-03-10 16:07","pubTimestamp":1741594054,"startTime":"0","endTime":"0","summary":"Hunan Warrant Pharmaceutical (SHA:688799) is planning to invest up to 500 million yuan in the phase two expansion of its high-end active pharmaceutical ingredient (API) and intermediate green manufact","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["OTX.SI","API","BK4023","688799","BK0239","API.AU","BK4503","BK4535","BK6100","BK4551","BK7103","BK6520"],"gpt_icon":0},{"id":"2514346627","title":"Guobang Pharma Subsidiary Gains Approval for Domestic Production of Cefuroxime Axetil API","url":"https://stock-news.laohu8.com/highlight/detail?id=2514346627","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514346627?lang=en_us&edition=fundamental","pubTime":"2025-02-28 17:46","pubTimestamp":1740735996,"startTime":"0","endTime":"0","summary":"Guobang Pharma's  subsidiary, Zhejiang Dongying, received approval from China's National Medical Products Administration to domestically produce its Cefuroxime Axetil Active Pharmaceutical Ingredient , according to a Friday filing with the Shanghai Bourse.The antibiotic treats respiratory, skin, and gonococcal infections. The API is also certified by the European EDQM.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["605507","BK7103","API.AU","OTX.SI","BK6520","BK4535","BK0239","BK4503","BK4551","BK6100","API","BK4023"],"gpt_icon":0},{"id":"2513126870","title":"Zhejiang Jianfeng Group Unit Secures Approval for API Market Entry","url":"https://stock-news.laohu8.com/highlight/detail?id=2513126870","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513126870?lang=en_us&edition=fundamental","pubTime":"2025-02-21 18:38","pubTimestamp":1740134287,"startTime":"0","endTime":"0","summary":"Zhejiang Jianfeng Group (SHA:600668) subsidiary Jianfeng Pharmaceutical obtained approval from China's drug administrator for active pharmaceutical ingredient (API) roxadustat.The approval is expected to expand the company's business scope, according to a Friday filing with the Shanghai bourse.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4023","API.AU","BK0188","API","BK4535","OTX.SI","BK0186","BK6100","BK6520","600668","BK7103","BK4551","BK4503","BK0235"],"gpt_icon":0},{"id":"2513237362","title":"Jiangxi Synergy Pharmaceutical Secures Drug Registration in South Korea","url":"https://stock-news.laohu8.com/highlight/detail?id=2513237362","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513237362?lang=en_us&edition=fundamental","pubTime":"2025-02-21 15:18","pubTimestamp":1740122304,"startTime":"0","endTime":"0","summary":"Jiangxi Synergy Pharmaceutical  said it received a drug registration certificate from South Korea's Ministry of Food and Drug Safety  for its empagliflozin active pharmaceutical ingredient , used in treating type 2 diabetes, according to a Wednesday filing with the Shenzhen Bourse.This approval grants the company market access in South Korea, supporting its international expansion. The certification was issued on Feb. 18.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4503","BK7103","BK4535","BK4551","BK4023","300636","API.AU","BK0239","API"],"gpt_icon":0},{"id":"2510879059","title":"Sinopep-Allsino Biopharmaceutical Passes GMP Inspections for APIs in South Korea, China","url":"https://stock-news.laohu8.com/highlight/detail?id=2510879059","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510879059?lang=en_us&edition=fundamental","pubTime":"2025-02-11 16:01","pubTimestamp":1739260870,"startTime":"0","endTime":"0","summary":"Jiangsu Sinopep-Allsino Biopharmaceutical  received good manufacturing practice compliance certifications from South Korea and China's Jiangsu province.These are semaglutide and fulvestrant active pharmaceutical ingredients  for export to South Korea as well as epalrestat and sodium picosulfate APIs for domestic production, according to a Tuesday filing with the Shanghai bourse.Shares of the biopharmaceutical company were down 3% in recent trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0239","BK4503","BK4535","API.AU","688076","BK4023","API","BK4551","BK7103"],"gpt_icon":0},{"id":"2506353430","title":"\"Nvidia's still a buy\": As China's ChatGPT moment rattles tech sector","url":"https://stock-news.laohu8.com/highlight/detail?id=2506353430","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506353430?lang=en_us&edition=fundamental","pubTime":"2025-01-28 08:33","pubTimestamp":1738024421,"startTime":"0","endTime":"0","summary":"The 17% plunge in Nvidia shares overnight is 'wildly overdone' as it changes almost nothing around the fundamental growth outlook for the chip manufacturer, according to Theo Mass, portfolio manager at Northcape Capital.The tech investing guru said China's Deepseek is a large language model  that focuses on the training phase of artificial intelligence , but the long-term growth market for AI remains the inference phase where trained models learn patterns to create predictions and offer solutions.\"My biggest point would be keep your eyes on the prize more than anything else,\" said Mr Maas. \"The biggest game in town that these guys  are going after is still inference AI over the next five to 10 years.\". Mr Maas said Northcape Capital still owns Nvidia shares and is bullish on its outlook. However, panicked investors wiped $US600 billion from its valuation on Monday around worries Deepseek will lower future demand for Nvidia's graphic processing units .","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/nvidia-s-still-a-buy-as-china-s-chatgpt-moment-rattles-tech-sector","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/nvidia-s-still-a-buy-as-china-s-chatgpt-moment-rattles-tech-sector","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["MNQmain","LU1989772923.USD","SQQQ","NVDD","LU0316494557.USD","AGI.AU","DDOG","LU0096364046.USD","LU1551013342.USD",".IXIC","NVDA","AVGO","BK4598","QID","NVD2.UK","TSYW.SI","USJW.SI","NVDU","NVDX","WDAY","LU0795875086.SGD","LU2491050154.USD","LU1868836914.USD","CRWD","API","NVDS","AMD","AGI","SNVD.UK","2NVD.UK","NVD","NVIW.SI","NVDY","QLD","PSQ","TQQQ","NVD3.UK","LU0323591593.USD","USAW.SI","LU0109391861.USD","3NVD.UK","API.AU","ADBE","NVDS.UK","LU0345770993.USD","LU1366192091.USD","LU0203347892.USD","NQmain"],"gpt_icon":1},{"id":"2503916068","title":"Asian Equities Traded in the US as American Depositary Receipts Advance in Thursday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2503916068","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503916068?lang=en_us&edition=fundamental","pubTime":"2025-01-16 23:36","pubTimestamp":1737041786,"startTime":"0","endTime":"0","summary":"Asian equities traded in the US as American depositary receipts were higher Thursday morning, up 0.3% to 2,083.58 on the S&P Asia 50 ADR Index.From North Asia, the gainers were led by live streaming platform Douyu  and software company Agora , which jumped 29% and 18% respectively. They were followed by live streaming platform Huya  and chipmaker Taiwan Semiconductor , which climbed 11% and 5.4% respectively.The decliners from North Asia were led by education companies TCTM Kids IT Education  and Ambow Education , which dropped 20% and 16% respectively.From South Asia, the gainers were led by tech conglomerate Sea , which rose 1%.The decliners from South Asia were led by pharmaceutical company Dr Reddy's Laboratories , which fell 3.7%, followed by tech companies Wipro , which was down 3.4%, and Infosys , which was shedding 1.5%.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4512","LU0823414478.USD","LU1282649067.USD","LU2054465674.USD","LU2250418816.HKD","SG9999002620.SGD","LU2125154778.USD","LU0889566641.SGD","LU0791590937.USD","BK4557","AFG","LU2506951792.HKD","LU0823421416.USD","SG9999000418.SGD","03145","LU0823414551.USD","RDY","IE00B7N09G41.SGD","SG9999004220.SGD","TSM","SG9999001135.SGD","WIT","LU1508157978.USD","BK4596","LU2294711713.HKD","BK4085","LU0231203729.USD","SG9999002679.SGD","LU2458330243.SGD","API","BK4526","LU0109392836.USD","LU0541502299.USD","TCTM","SG9999014484.SGD","HUYA","RDY.AU","LU1868837565.USD","AMBO","SE","BK4591","IE00BQXX3F31.USD","LU2125154935.USD","INFY","LU2237443978.SGD","BK4585","LU0353189680.USD","LU0572939691.SGD","API.AU","DOYU"],"gpt_icon":1},{"id":"2503738669","title":"JiangSu WuZhong Pharmaceutical Development Gets Registration for Eperisone Hydrochloride API","url":"https://stock-news.laohu8.com/highlight/detail?id=2503738669","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503738669?lang=en_us&edition=fundamental","pubTime":"2025-01-15 14:22","pubTimestamp":1736922125,"startTime":"0","endTime":"0","summary":"JiangSu WuZhong Pharmaceutical Development (SHA:600200) secured registration approval for eperisone hydrochloride active pharmaceutical ingredient (API) from China's drug regulator.Eperisone hydrochlo","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0028","BK4023","BK4551","BK4535","BK4503","BK6520","OTX.SI","BK0012","BK0239","BK7103","BK6100","BK0188","API.AU","API","600200","BK0060"],"gpt_icon":0},{"id":"2503514909","title":"Tianyao Pharmaceuticals Gets China Registration Approval for Formoterol API","url":"https://stock-news.laohu8.com/highlight/detail?id=2503514909","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503514909?lang=en_us&edition=fundamental","pubTime":"2025-01-14 15:36","pubTimestamp":1736840165,"startTime":"0","endTime":"0","summary":"Tianjin Tianyao Pharmaceuticals (SHA:600488) secured registration approval for formoterol fumarate active pharmaceutical ingredient (API) from China's drug administrator.Formoterol fumarate is used to","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0239","OTX.SI","600488","BK4503","BK7103","API","BK4551","BK4535","BK6100","BK0012","API.AU","BK0028","BK4023","BK6520","BK0102"],"gpt_icon":0},{"id":"2503329545","title":"Zhejiang Cheng Yi Pharmaceutical Passes TGA-GMP Certification for Two APIs","url":"https://stock-news.laohu8.com/highlight/detail?id=2503329545","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503329545?lang=en_us&edition=fundamental","pubTime":"2025-01-13 15:38","pubTimestamp":1736753897,"startTime":"0","endTime":"0","summary":"Zhejiang Cheng Yi Pharmaceutical  passed Australia's Therapeutic Goods Administration-Good Manufacturing Practice certification for two active pharmaceutical ingredients .Azathioprine API is mainly used for immunosuppression and treating tumors, while mercaptopurine API is an anti-tumor compound, according to a Jan. 10 filing with the Shanghai bourse.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4551","XAO.AU","BK7103","OTX.SI","API.AU","XJO.AU","TGA","BK4023","BK0239","BK6100","BK4213","BK6520","XKO.AU","603811","API","BK4503","BK4535"],"gpt_icon":0},{"id":"2500916494","title":"Tianjin Tianyao Pharmaceuticals Gets Listing Approval for Dexamethasone Sodium Phosphate API in Brazil","url":"https://stock-news.laohu8.com/highlight/detail?id=2500916494","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500916494?lang=en_us&edition=fundamental","pubTime":"2025-01-02 15:55","pubTimestamp":1735804544,"startTime":"0","endTime":"0","summary":"Tianjin Tianyao Pharmaceuticals (SHA:600488) secured registration approval for dexamethasone sodium phosphate active pharmaceutical ingredient (API) from Brazil's health surveillance agency.Dexamethas","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4023","BK0028","BK6501","5WV.SI","BK4551","BK0012","BK6031","BK6520","BK0102","API","OTX.SI","API.AU","BK4503","BK4535","BK7103","600488","BK6100","BK0239"],"gpt_icon":0},{"id":"2488674051","title":"Sector Update: Tech Stocks Mixed Premarket Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=2488674051","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488674051?lang=en_us&edition=fundamental","pubTime":"2024-12-02 22:06","pubTimestamp":1733148376,"startTime":"0","endTime":"0","summary":"Technology stocks were mixed premarket Monday as the Technology Select Sector SPDR Fund (XLK) was down 0.1% and the SPDR S&P Semiconductor ETF (XSD) was up 0.9% recently.Agora (API) shares rose past 4","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XSD","BK4551","LSPD","BK4588","BK7103","API.AU","BK4123","BK4585","BK4535","NOTE","XLK","BK4503","API","BK4023"],"gpt_icon":1},{"id":"2488739516","title":"Agora Senior Management Team Signs Voluntary Lock-Up Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2488739516","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488739516?lang=en_us&edition=fundamental","pubTime":"2024-12-02 20:17","pubTimestamp":1733141852,"startTime":"0","endTime":"0","summary":"Agora  said Monday that its senior management team voluntarily entered into a lock-up period for company shares owned by them and entities they control.The management team includes Chief Executive Officer Bin Zhao and Chief Financial Officer Jingbo Wang, among others.According to the company, the group agreed not to sell any Agora shares through Dec. 31, 2025, except for the 400,000 American depositary shares that Chief Technology Officer Sheng Zhong is selling for personal financial reasons.Agora shares were up more than 3% in recent premarket activity.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4120","BK4023","BK4535","API","TISI","BK4551","BK7103","BK4503","API.AU"],"gpt_icon":1},{"id":"2487565661","title":"Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2487565661","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2487565661?lang=en_us&edition=fundamental","pubTime":"2024-11-29 23:27","pubTimestamp":1732894063,"startTime":"0","endTime":"0","summary":"Asian equities traded in the US as American depositary receipts were higher on Friday morning, rising 0.6% to 2,039.94 on the S&P Asia 50 ADR Index.From North Asia, the gainers were led by computer hardware manufacturer Canaan  and game live streaming platform Huya , which advanced 14.8% and 3.8% respectively. They were followed by pharmaceutical company Beigene , which added 3.1%.The decliners from North Asia were led by software company Agora  and healthcare platform 111 , which fell 13.7% and 3.9% respectively.From South Asia, the gainers were led by telecoms company Telkom Indonesia  and pharmaceutical company Dr. Reddy's Laboratories , which rose 1.5% and 0.4% respectively.The decliners from South Asia were led by Indian banks HDFC  and ICICI , which fell 1.3% and 1.2% respectively.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4504","AFG","BK7016","RDY.AU","API.AU","LU0181495838.USD","SG9999014005.SGD","IE00BYTNYM70.SGD","LU0164881194.USD","LU2177674079.SGD","TLK","BK4007","LU0431992006.USD","BK4526","RDY","BK4551","LU0531971678.HKD","IE00B7N09G41.SGD","LU0828237940.HKD","BK4509","LU0348744763.USD","BK7508","BK4596","LU0348816934.USD","LU0797268264.HKD","LU1868837722.USD","YI","HUYA","LU1804176565.USD","LU0348814723.USD","LU1102505929.USD","BK4548","LU0918141887.USD","IBN","BK4557","LU0823039010.USD","LU0708995666.HKD","HDB","LU0528227936.USD","LU1854104046.USD","LU0251143458.SGD","SG9999004220.SGD","BK4566","LU1102505762.USD","CAN.AU","BGNE","LU0868486357.SGD","BK4023","CAN","API"],"gpt_icon":1},{"id":"2481511566","title":"Are Wesfarmers or Sigma shares a better buy in the pharmacy arena?","url":"https://stock-news.laohu8.com/highlight/detail?id=2481511566","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481511566?lang=en_us&edition=fundamental","pubTime":"2024-11-08 12:23","pubTimestamp":1731039780,"startTime":"0","endTime":"0","summary":"The key reason the market is very excited about Sigma is its impending merger with Chemist Warehouse, now approved by the ACCC, to create a strong player in the space. Sigma's recent FY25 half-year result was solid, with 17% net revenue growth to $1.84 billion and 20.6% growth of EBIT to $18 million. It's clear the Wesfarmers' healthcare division is larger than Sigma. However, Sigma Healthcare will become a much more profitable business once combined with Chemist Warehouse, which recently reported its ownFY24 result, which showed $3.3 billion in revenue and, most importantly, $540 million in net profit. The combination of the two businesses is expected to unlock \"significant efficiencies\", with cost synergies estimated at an initial $60 million per a","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2024/11/08/are-wesfarmers-or-sigma-shares-a-better-buy-in-the-pharmacy-arena/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["SIG.AU","XKO.AU","BK4023","WES.AU","XAO.AU","BK7041","EBIT","BK4503","BK7511","BK4551","BK4535","API","BK7103","API.AU","BK7153","XJO.AU"],"gpt_icon":0},{"id":"2477503682","title":"Indonesian Court Declares Textile Giant Sritex Bankrupt","url":"https://stock-news.laohu8.com/highlight/detail?id=2477503682","media":"Tempo","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477503682?lang=en_us&edition=fundamental","pubTime":"2024-10-24 16:48","pubTimestamp":1729759735,"startTime":"0","endTime":"0","summary":"TEMPO.CO, Jakarta - Jemmy Kartiwa Sastratmaja, the Chair of the Indonesian Textile Association , said the textile giant Sritex’s bankruptcy is inseparable from the global economic slowdown that prompted the influx of products from China and heavily affected the Indonesian textile industry.\"The main problem originates from the global economic slowdown that started with high inflation and interest rate hikes in various parts of the world, including Indonesia,\" Jemmy told Tempo on Thursday, October 24, 2024.This condition triggered a drop in purchasing power in countries like the United States and the European Union. In consequence, major textile producers like China experience an oversupply, which causes their products to flood the markets of various countries.","market":"nz","thumbnail":"https://statik.tempo.co/data/2020/12/21/id_989246/989246_720.jpg","type":0,"news_type":0,"thumbnails":["https://statik.tempo.co/data/2020/12/21/id_989246/989246_720.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://en.tempo.co/read/1932678/indonesian-court-declares-textile-giant-sritex-bankrupt","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tempo_highlight","symbols":["BK4503","API.AU","API","BK7103","BK4023","BK4551","BK4535"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":17,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/API.AU\",params:#limit:5,,,undefined,":[{"date":"2022-10-20","symbol":"API.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1666220400000,"name":null,"time":"","dateTimestamp":1666184400000,"actualEps":null},{"date":"2022-04-21","symbol":"API.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1650499200000,"name":null,"time":"","dateTimestamp":1650463200000,"actualEps":null},{"market":"AU","date":"2022-04-04","symbol":"API.AU","reason":null,"defaultRemindTime":1649030400000,"announcedDate":"2022-04-01","type":"delisting","dateTimestamp":1648994400000},{"market":"AU","date":"2022-03-24","symbol":"API.AU","amount":0.03,"defaultRemindTime":1648076400000,"name":"Australian Pharma Industries","recordDate":"2022-03-29","payableDate":"2022-03-25","currency":"AUD","type":"dividend","dateTimestamp":1648040400000},{"market":"AU","date":"2021-11-11","symbol":"API.AU","amount":0.02,"defaultRemindTime":1636585200000,"name":"Australian Pharma Industries","recordDate":"2021-12-15","payableDate":"2021-11-12","currency":"AUD","type":"dividend","dateTimestamp":1636549200000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"API.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-11-11","recordDate":"2020-11-12","paymentDate":"2020-12-15","value":0.02,"currency":"AUD"},{"executeDate":"2021-05-06","recordDate":"2021-05-07","paymentDate":"2021-06-04","value":0.015,"currency":"AUD"},{"executeDate":"2021-11-11","recordDate":"2021-11-12","paymentDate":"2021-12-15","value":0.02,"currency":"AUD"},{"executeDate":"2022-03-24","recordDate":"2022-03-25","paymentDate":"2022-03-29","value":0.03,"currency":"AUD"}]}}